These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. New possibilities of treatment for panic attacks in elderly patients: escitalopram versus citalopram. Rampello L; Alvano A; Raffaele R; Malaguarnera M; Vecchio I J Clin Psychopharmacol; 2006 Feb; 26(1):67-70. PubMed ID: 16415709 [TBL] [Abstract][Full Text] [Related]
43. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Lavretsky H; Reinlieb M; St Cyr N; Siddarth P; Ercoli LM; Senturk D Am J Psychiatry; 2015 Jun; 172(6):561-9. PubMed ID: 25677354 [TBL] [Abstract][Full Text] [Related]
44. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128 [TBL] [Abstract][Full Text] [Related]
45. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074 [TBL] [Abstract][Full Text] [Related]
46. Debunking the placebo effect in depression: the effect of patient and investigator expectation on escitalopram efficacy. Nehama Y; Rabinowitz I; Baruch Y; Mandel A; Lurie I; Barak Y Int Clin Psychopharmacol; 2014 Mar; 29(2):106-10. PubMed ID: 24172161 [TBL] [Abstract][Full Text] [Related]
47. Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: an open trial. Scantamburlo G; Hansenne M; Geenen V; Legros JJ; Ansseau M Eur Psychiatry; 2015 Jan; 30(1):65-8. PubMed ID: 25282363 [TBL] [Abstract][Full Text] [Related]
49. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Moore N; Verdoux H; Fantino B Int Clin Psychopharmacol; 2005 May; 20(3):131-7. PubMed ID: 15812262 [TBL] [Abstract][Full Text] [Related]
50. A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder. Bystritsky A; Kerwin L; Feusner JD; Vapnik T Psychopharmacol Bull; 2008; 41(1):46-51. PubMed ID: 18362870 [TBL] [Abstract][Full Text] [Related]
51. Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials. Noma H; Furukawa TA; Maruo K; Imai H; Shinohara K; Tanaka S; Ikeda K; Yamawaki S; Cipriani A J Affect Disord; 2019 May; 250():419-424. PubMed ID: 30878654 [TBL] [Abstract][Full Text] [Related]
52. Treatment of maternal depression in a medication clinical trial and its effect on children. Weissman MM; Wickramaratne P; Pilowsky DJ; Poh E; Batten LA; Hernandez M; Flament MF; Stewart JA; McGrath P; Blier P; Stewart JW Am J Psychiatry; 2015 May; 172(5):450-9. PubMed ID: 25615566 [TBL] [Abstract][Full Text] [Related]
53. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial. Brunoni AR; Carracedo A; Amigo OM; Pellicer AL; Talib L; Carvalho AF; Lotufo PA; Benseñor IM; Gattaz W; Cappi C Braz J Psychiatry; 2020 Apr; 42(2):128-135. PubMed ID: 31721892 [TBL] [Abstract][Full Text] [Related]
54. A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. Lydiatt WM; Denman D; McNeilly DP; Puumula SE; Burke WJ Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):528-35. PubMed ID: 18490576 [TBL] [Abstract][Full Text] [Related]
55. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study. Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208 [TBL] [Abstract][Full Text] [Related]
56. The onset of effect for escitalopram and its relevance for the clinical management of depression. Wade A; Friis Andersen H Curr Med Res Opin; 2006 Nov; 22(11):2101-10. PubMed ID: 17076970 [TBL] [Abstract][Full Text] [Related]
57. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799 [TBL] [Abstract][Full Text] [Related]
58. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report. Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ; Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340 [TBL] [Abstract][Full Text] [Related]
59. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683 [TBL] [Abstract][Full Text] [Related]
60. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials. Li H; Li T; Li G; Luo J Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]